FI
ASND icon

Fosun International’s Ascendis Pharma A/S ASND Stock Holding History

Fosun International’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-74,689
Closed -$8.1M – 239
2019
Q2 		$8.1M Buy
74,689
+7,263
+11% +$869K 0.53% 31
2019
Q1 		$7.77M Buy
67,426
+14,100
+26% +$1.23M 0.49% 32
2018
Q4 		$3.25M Hold
53,326
– – 0.19% 59
2018
Q3 		$3.54M Buy
+53,326
New +$3.67M 0.17% 62

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fosun International's ASND Position: Q3 2019 in Review

Fosun International sold out of Ascendis Pharma A/S (ASND) in Q3 2019, closing a stake of 74,689 shares — an estimated $8.1M sold.

Fosun International first reported a position in ASND in Q3 2018 and held it in 4 quarters. The position peaked at $8.1M in Q2 2019. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

  • Fosun International reported no remaining Ascendis Pharma A/S position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 74,689 Ascendis Pharma A/S shares in Q3 2019, an estimated $8.1M.
  • Fosun International first reported a position in Ascendis Pharma A/S in Q3 2018 and held it in 4 quarters.
  • Fosun International's Ascendis Pharma A/S position peaked at $8.1M in Q2 2019.
  • 129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.